Evidence map›Paper›PMID 31109948›Full record

ArticleInfection and immunity2019

Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.

Brian A Vega, Liam T Schober, Tami Kim, Benjamin A Belinka, Scott C Kachlany

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. [The Oral Microbiome: Maintenance of Homeostasis, Disease Associations, and Mechanisms of Pathogenesis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  2. Article
  3. Fimbriae potentiateCurrent research in microbial sciences · 2026
    Review
  4. Journal of oral microbiology · 2026
    Review
  5. Review
  6. Therapeutic Applications ofPathogens (Basel, Switzerland) · 2024
    Review
  7. Microorganisms · 2022
    Review
  8. Toxins · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Toxins · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brian A VegaDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, New Jersey, USA.
Liam T SchoberDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, New Jersey, USA.
Tami KimDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, New Jersey, USA.
Benjamin A BelinkaActinobac Biomed, Inc., Princeton, New Jersey, USA.
Scott C KachlanyDepartment of Oral Biology, Rutgers School of Dental Medicine, Newark, New Jersey, USA kachlasc@rutgers.edu.
Rutgers, The State University of New Jersey · USActinobac Biomed (United States) · US

Funding

Program in Infection, Immunity and InflammationT32AI125185 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI SALGAME, PADMINI · 2016 to 2020
$747k
Targeting B-cell lymphoma with LeukotheraR41CA173900 · NCI · ACTINOBAC BIOMED, INC. · PI BELINKA, BENJAMIN A · 2012 to 2013
$311k
NCI NIH HHS R41 CA173900NIAID NIH HHS T32 AI125185
6 · The paper itself

Abstract

Leukotoxin (LtxA) (trade name, Leukothera) is a protein secreted by the oral bacterium

Indexed as

CaspasesCD11a AntigenCD18 AntigensCell DeathExotoxinsfas ReceptorHumansJurkat CellsLymphocyte Function-Associated Antigen-1T-LymphocytesVirulence FactorsCaspasesCD11a AntigenCD18 AntigensExotoxinsfas ReceptorleukotoxinLymphocyte Function-Associated Antigen-1Virulence Factorsautoimmunitycell deathCRISPRdeath receptorinflammationintegrinsleukemialymphomaoral microbiologyperiodontal disease

Identifiers

PMID31109948
PMCPMC6652782
OpenAlexW2945710230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.